Skip to main content
Skip to navigation
hot-topics
Extras
Newsletters
Jobs
Reading room
Puzzles
Royal Society of Chemistry
Publishing
Education
Membership
Chemistry World
cw-logo
Mast navigation
Sign In
Register
Subscribe
Search our site
Search our site
Search
Menu
Close
menu
Home
News
Research
Industry
Opinion
Features
Culture
Careers
Podcasts
Webinars
Collections
Back
to parent navigation item
Collections
Women's health
Solutions for India's sustainability challenge
The future of analytical chemistry
Chemistry of the brain
Water and the environment
Chemical bonding
Antimicrobial resistance
Energy storage and batteries
AI and automation
Sustainability
Research culture
Nobel prize
Food science and cookery
Plastics and polymers
Periodic table
Coronavirus
Members
Home
News
Research
Industry
Opinion
Features
Culture
Careers
Podcasts
Webinars
Collections
Women's health
Solutions for India's sustainability challenge
The future of analytical chemistry
Chemistry of the brain
Water and the environment
Chemical bonding
Antimicrobial resistance
Energy storage and batteries
AI and automation
Sustainability
Research culture
Nobel prize
Food science and cookery
Plastics and polymers
Periodic table
Coronavirus
Members
More
navigation items
News
Nanobody inflammation drug attracts Abbvie
By
Phillip Broadwith
2013-09-25T00:00:00
$840m licensing deal shows support for antibody fragments